Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the random (Q42951430)
Jump to navigation
Jump to search
scientific article published on August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the random |
scientific article published on August 2010 |
Statements
1 reference
Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the random (English)
1 reference
Juan González-García
1 reference
Daniel Cohen
1 reference
Margaret Johnson
1 reference
Louis Sloan
1 reference
Linda Fredrick
1 reference
Christian Naylor
1 reference
Barbara da Silva
1 reference
Barry Bernstein
1 reference
M05-730 Study Group
1 reference
1 August 2010
1 reference
1 reference
Identifiers
1 reference